Skip to content

PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring

Preterm Neonate/ Neonatal Embedded Universal Microelectronic Wearable Acquisition for Cardio Respiratory Intensive Therapy. Clinical Assessment of Device Usability and Reliability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06171867
Acronym
PNEUMACRIT
Enrollment
20
Registered
2023-12-15
Start date
2023-11-24
Completion date
2024-02-25
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Respiratory Distress

Keywords

Electrical impedance tomography, neonate

Brief summary

The usability of a new PNEUMACRIT system is studied in clinical environment in this feasibility study.

Detailed description

Electrical impedance tomography is a noninvasive monitoring tool for neonatal lung aeration and breathing. This feasibility study will assess the usability of a new PNEUMACRIT electrode belt in clinical environment.

Interventions

DEVICEPNEUMACRIT

Monitoring of breathing

Sponsors

Middlesex University
CollaboratorOTHER
University of Oulu
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

The device feasibility will be assessed in clinical environment with feedback from both the patient parents and nurses in NICU/PICU.

Eligibility

Sex/Gender
ALL
Age
12 Hours to 6 Months
Healthy volunteers
No

Inclusion criteria

* Inpatient at Oulu University Hospital PICU or NICU * Gestational age at birth over 32 weeks * Weight 2000-5000g * Postnatal age \> 12 hours * Written informed consent from the parents of legal representative * Non-invasive monitoring of oxygen saturation and ECG

Exclusion criteria

* Postmenstrual age \< 32 weeks * Weight at time of the study \< 2000g or \> 5000g * Chest skin lesion preventing safe use of the electrode belt * Recent chest surgery within the past 7 days (e.g. thoracotomy)

Design outcomes

Primary

MeasureTime frameDescription
Proportion (%) of recording time with high quality EIT-signal6-24 hoursProportion of time that the collected EIT signal is accurate enough for reliable image reconstruction and observations of changes in lung aeration

Secondary

MeasureTime frameDescription
Staff and parent questionnaires48 hoursAfter the study period, the patient parents and nurses will give feedback on the device and its feasibility with a structured questionnaire including also free text fields

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026